Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Andrew M. Churg
Based on 21 articles published since 2008
||||
Expertise Level
The expertise of Andrew M. Churg ranks in the
  • Top 0.28%
  • ... of 15,462 published authors worldwide on Mesothelioma
  • ... from 2008 through 2018
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Churg, Andrew M   ·   Churg, Andrew
Work Locations
Details
Most likely:    University of British Columbia      
2017
  • Department of Pathology Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: · Department of Pathology, MESOPATH-MESOBANK, Centre León Bérard, Lyon, France. · Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan. · Interhospital Pathology Division, Università degli Studi di Milano and IRCCS MultiMedica Group, Milan, Italy. · Department of Pathology University of Wales and Cardiff University, Cardiff, U.K. · Department of Pathology, University of British Columbia, Vancouver, BC. · Department of Pathology, Brigham and Women's Hospital, Boston, MA. · Department of Pathology UPMC-PUH, Pittsburgh, PA. · Department of Pathology, Chicago University, Chicago, IL. · Department of Pathology, Mayo Clinic, Jacksonville, FL. · SA Pathology at Flinders Medical Cemtre, Bedord Park, SA. · Department of Pathology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France. · Department of Pathology Duke University, Durham, NC. · Department of Pathology, CHU de Nancy, Nancy, France. · University Hospital Leuven, Leuven, Belgium. · Department of Pathology Sloan Kettering Memorial Cancer Center, New York, NY. · Department of Pathology Fukuoka University Hospital, Fukuoka, Japan. · Pubmed 28782639
2016
  • Department of Pathology, Centre Hospitalier Universitaire Caen, Caen, France; Department of Biopathology, Centre Leon Berard, Lyon, France. · Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Pathology, Duke University Medical Center, Durham, NC, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 26811225
  • 1   Departments of Pathology and Laboratory Medicine and. · 2   Department of Pathology and. · 3   Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada; · 4   Medical Genetics, University of British Columbia, Vancouver, Canada; · 5   Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Pubmed 27128293
2015
  • University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada. · British Columbia Cancer Agency, Division of Medical Oncology, Vancouver Centre, Vancouver, Canada. · Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada. · PhenoPath Laboratories, Seattle, Washington, United States of America. · University of British Columbia, Department of Surgery, Surgical Oncology, Vancouver, Canada. · University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada; PhenoPath Laboratories, Seattle, Washington, United States of America. · Pubmed 25798586
2012
  • Department of Pathology, G227, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada. · Pubmed 23020727
2011
  • Department of Pathology, University of British Columbia, Vancouver, BC, Canada. · Pubmed 21959310
2009
  • Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: · Departments of Pathology, University of British Columbia, Vancouver, BC, Canada. · Medicine, University of British Columbia, Vancouver, BC, Canada. · Pubmed 19736198
2018
  • From the Department of Pathology, University of Chicago Medical Center, Chicago, Illinois (Drs Husain and Krausz); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Dr Colby, emeritus); the Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Cellular Pathology, University Hospital of Wales and Cardiff University, Cardiff, South Glamorgan, Wales (Dr Attanoos); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, University of Vermont College of Medicine, Burlington (Dr Butnor); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); Centre National Référent MESOPATH Departement de Biopathologie, Lyon Cedex, France (Dr Galateau-Sallé); the Department of Pathology, University Hospital of Wales, Penarth, South Glamorgan, Wales (Dr Gibbs); the Department of Pathology, PhenoPath Laboratories, Seattle, Washington (Dr Gown); the Department of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, (Dr Litzky); the Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Drs Marchevsky and Walts); the Department of Histopathology, Royal Brompton & Harefield National Health Service Foundation Trust and the National Heart and Lung Institute, Imperial College, Chelsea, London, England (Dr Nicholson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Department of Pathology, University of Pittsburgh, and the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr Sharma); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Travis); and the Department of Pathology, University of Virginia Medical Center, Charlottesville (Dr Wick). · Pubmed 28686500
2017
  • *Department of Pathology, University of British Columbia †Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada. · Pubmed 28614203
2016
  • From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley). · Pubmed 27031777
  • *PhenoPath Laboratories, Seattle, WA †Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26900815
  • *PhenoPath Laboratories, Seattle, WA †Department of Pathology, Vancouver General Hospital ‡Department of Pathology, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26448191
  • From the Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (Drs Churg and Sheffield); and Service Anatomie Pathologique, Centre National Référent MESOPATH, CHU du Caen, Caen, France (Dr Galateau-Salle). Dr Galateau-Salle is now with the Department of Pathology, Centre Leon Berard, Lyon, France. · Pubmed 26288396
2015
  • *Division of Anatomical Pathology, Vancouver General Hospital ‡Division of Anatomical Pathology, Children's and Women's Hospital of British Columbia, Vancouver, BC, Canada †PhenoPath Laboratories, Seattle, WA. · Pubmed 25634745
2014
  • *Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy. · Pubmed 24618613
  • *PhenoPath Laboratories, Seattle, WA †Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada. · Pubmed 24503757
2013
  • Division of Anatomical Pathology, Vancouver General Hospital, Vancouver, BC, Canada. · Pubmed 23108021
2012
  • Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada. · Pubmed 22982894
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Andrew M. Churg about Mesothelioma:

  • Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. 2018
  • The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. 2017
  • GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung. 2017
  • The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. 2016
  • Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations. 2016
  • Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR). 2016
  • BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas. 2016
  • Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens. 2016
  • New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet? 2016
  • Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. 2015
Show List of Full Article Records
Google Searches

Learn more about Andrew M. Churg using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of British Columbia
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of British Columbia
2017
  • Department of Pathology Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: · Department of Pathology, MESOPATH-MESOBANK, Centre León Bérard, Lyon, France. · Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan. · Interhospital Pathology Division, Università degli Studi di Milano and IRCCS MultiMedica Group, Milan, Italy. · Department of Pathology University of Wales and Cardiff University, Cardiff, U.K. · Department of Pathology, University of British Columbia, Vancouver, BC. · Department of Pathology, Brigham and Women's Hospital, Boston, MA. · Department of Pathology UPMC-PUH, Pittsburgh, PA. · Department of Pathology, Chicago University, Chicago, IL. · Department of Pathology, Mayo Clinic, Jacksonville, FL. · SA Pathology at Flinders Medical Cemtre, Bedord Park, SA. · Department of Pathology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France. · Department of Pathology Duke University, Durham, NC. · Department of Pathology, CHU de Nancy, Nancy, France. · University Hospital Leuven, Leuven, Belgium. · Department of Pathology Sloan Kettering Memorial Cancer Center, New York, NY. · Department of Pathology Fukuoka University Hospital, Fukuoka, Japan. · Pubmed 28782639
2016
  • Department of Pathology, Centre Hospitalier Universitaire Caen, Caen, France; Department of Biopathology, Centre Leon Berard, Lyon, France. · Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Pathology, Duke University Medical Center, Durham, NC, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 26811225
  • 1   Departments of Pathology and Laboratory Medicine and. · 2   Department of Pathology and. · 3   Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada; · 4   Medical Genetics, University of British Columbia, Vancouver, Canada; · 5   Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Pubmed 27128293
2015
  • University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada. · British Columbia Cancer Agency, Division of Medical Oncology, Vancouver Centre, Vancouver, Canada. · Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada. · PhenoPath Laboratories, Seattle, Washington, United States of America. · University of British Columbia, Department of Surgery, Surgical Oncology, Vancouver, Canada. · University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada; PhenoPath Laboratories, Seattle, Washington, United States of America. · Pubmed 25798586
2012
  • Department of Pathology, G227, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada. · Pubmed 23020727
2011
  • Department of Pathology, University of British Columbia, Vancouver, BC, Canada. · Pubmed 21959310
2009
  • Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: · Departments of Pathology, University of British Columbia, Vancouver, BC, Canada. · Medicine, University of British Columbia, Vancouver, BC, Canada. · Pubmed 19736198
2018
  • From the Department of Pathology, University of Chicago Medical Center, Chicago, Illinois (Drs Husain and Krausz); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Dr Colby, emeritus); the Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Cellular Pathology, University Hospital of Wales and Cardiff University, Cardiff, South Glamorgan, Wales (Dr Attanoos); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, University of Vermont College of Medicine, Burlington (Dr Butnor); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); Centre National Référent MESOPATH Departement de Biopathologie, Lyon Cedex, France (Dr Galateau-Sallé); the Department of Pathology, University Hospital of Wales, Penarth, South Glamorgan, Wales (Dr Gibbs); the Department of Pathology, PhenoPath Laboratories, Seattle, Washington (Dr Gown); the Department of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, (Dr Litzky); the Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Drs Marchevsky and Walts); the Department of Histopathology, Royal Brompton & Harefield National Health Service Foundation Trust and the National Heart and Lung Institute, Imperial College, Chelsea, London, England (Dr Nicholson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Department of Pathology, University of Pittsburgh, and the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr Sharma); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Travis); and the Department of Pathology, University of Virginia Medical Center, Charlottesville (Dr Wick). · Pubmed 28686500
2017
  • *Department of Pathology, University of British Columbia †Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada. · Pubmed 28614203
2016
  • From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley). · Pubmed 27031777
  • *PhenoPath Laboratories, Seattle, WA †Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26900815
  • *PhenoPath Laboratories, Seattle, WA †Department of Pathology, Vancouver General Hospital ‡Department of Pathology, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26448191
  • From the Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (Drs Churg and Sheffield); and Service Anatomie Pathologique, Centre National Référent MESOPATH, CHU du Caen, Caen, France (Dr Galateau-Salle). Dr Galateau-Salle is now with the Department of Pathology, Centre Leon Berard, Lyon, France. · Pubmed 26288396
2015
  • *Division of Anatomical Pathology, Vancouver General Hospital ‡Division of Anatomical Pathology, Children's and Women's Hospital of British Columbia, Vancouver, BC, Canada †PhenoPath Laboratories, Seattle, WA. · Pubmed 25634745
2014
  • *Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy. · Pubmed 24618613
  • *PhenoPath Laboratories, Seattle, WA †Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada. · Pubmed 24503757
2013
  • Division of Anatomical Pathology, Vancouver General Hospital, Vancouver, BC, Canada. · Pubmed 23108021
2012
  • Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada. · Pubmed 22982894
Unspecified
2016
  • 1   Departments of Pathology and Laboratory Medicine and. · 2   Department of Pathology and. · 3   Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada; · 4   Medical Genetics, University of British Columbia, Vancouver, Canada; · 5   Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Pubmed 27128293
38 Other Locations Show
Yearly article counts 12622221030
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.